Stock & Company Details
ImmunityBio Inc $IBRX
Price:
N/A
N/A
1.1B
$11B
52 Week High:
N/A
10 Day Average Volume:
N/A
-10.23
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
IBRX technical indicators
Latest ImmunityBio Inc (IBRX) indicator readings as of 2026-10-08.
IBRX's 14-day RSI is 62.5, in neutral territory. ADX reads 42.5, indicating a trending market. MACD (12, 26, 9) is 0.50, above the zero line.
IBRX backtested strategy results
How 4 rule-based strategies performed on ImmunityBio Inc (IBRX) over recent history, last backtested 2026-09-03. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +353.2% | 27% | 22 | -36.1% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -34.9% | 17% | 35 | -85.6% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -56.4% | 22% | 32 | -89.5% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | -90.0% | 23% | 44 | -90.5% |
Overview
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.
Finance Bot
Ask your questions
Start by typing a question below.
